Which treatments help women with reduced libido?

Journal of Family Practice

Volumn 62, Issue 2, 2013, Pages

  Hobbs, Keia ^a   Handler, Lara ^a   Mounsey, Anne L ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TESTOSTERONE; PHOSPHODIESTERASE V INHIBITOR; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE;

ARTICLE; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; LIBIDO DISORDER; POSTMENOPAUSE; SEXUAL FUNCTION; SUSTAINED DRUG RELEASE; DRUG EFFECT; FEMALE; INTRADERMAL DRUG ADMINISTRATION; LIBIDO; REVIEW; SEXUAL DYSFUNCTION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; FEMALE; HUMANS; LIBIDO; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PURINES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SULFONES; TESTOSTERONE; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84875911174     PISSN: 00943509     EISSN: 15337294     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Panay N, Al-Azzawi F, Bouchard C, et al. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric. 2010;13:121-131.
2. Davis SR, Moreau M, et al. Testosterone for low libido in women not taking estrogen. N Engl J Med. 2008;359:2005-2017.
3. Safarinejad MR, Hosseini SY, Asgari MA, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women. BJU Int. 2010;106:832-839.
4. Segraves RT, Clayton A, Croft H, et al. Buproprion sustained release for the treatment of hypoactive sexual desire in premenopausal women. J Clin Psychopharmacol. 2004;24:339-342. (Pubitemid 38658043)
5. Nurnberg HG, Hensley PL, Heiman JR, et al. Sildenafil treatment of women with antidepressant-associated sexual dysfunction. JAMA. 2008;300:395-404. (Pubitemid 352040251)
6. Basson R, McInnes R, Smith MD, et al. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med. 2002;11:367-377.
7. Wierman M, Basson R, Davis SR, et al. Androgen therapy in women: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2006;91:3697-3710. (Pubitemid 44536831)
8. Braunstein GD. The Endocrine Society Clinical Practice Guideline and The North American Menopause Society position statement on androgen therapy in women: another one of Yogi's forks. J Clin Endocrinol Metab. 2007;92:4091-4093. (Pubitemid 350074716)